These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4808355)

  • 1. Observations with Libexin-c in bronchopulmonary syndromes.
    Halmos T; Salamon F
    Ther Hung; 1973; 21(3-4):149-51. PubMed ID: 4808355
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of the antitussive action of libexin and baltix].
    Shul'gin AV; Abramova VG; Votchal OA
    Ter Arkh; 1975; 47(3):140-2. PubMed ID: 779093
    [No Abstract]   [Full Text] [Related]  

  • 3. Libexin combinatum in the treatment of patients suffering from chronic respiratory tract diseases.
    Gergely I
    Ther Hung; 1978; 26(3):136-8. PubMed ID: 725818
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative investigation of Libexin and Hydrocodin.
    Kiss J; Pongor F; Nagy M
    Ther Hung; 1968; 16(2):79-82. PubMed ID: 5666419
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical use of Libexin, a new peripheral antitussive.
    Rédey T; Skoda E
    Ther Hung; 1967; 15(3):117-9. PubMed ID: 4866485
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on the antitussive effect of Libexin in clinical practice].
    Hankovszky M; Károlyi A
    Orv Hetil; 1966 Jul; 107(30):1427-8. PubMed ID: 5968420
    [No Abstract]   [Full Text] [Related]  

  • 7. [Report on a multi-center study of a new prenoxdiazine antitussive agent].
    Wieser O; Maieron B
    Z Allgemeinmed; 1973 Jun; 49(16):805-9. PubMed ID: 4576446
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of the combination prenoxidiazine-S-carboxy-methyl-cysteine].
    Alesina R; Caliandro L; Cerveri I; Scala C
    G Clin Med; 1979 Feb; 60(2):136-54. PubMed ID: 378746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical, respiratory functional, bacteriological and immunological observations on the use of Bisolvon].
    Bernardini V; Camerota G; Baronti A; Curti PC
    Minerva Med; 1969 Sep; 60(75):3514-20. PubMed ID: 4186563
    [No Abstract]   [Full Text] [Related]  

  • 10. [On rational drug therapy of nonspecific bronchitic syndrome].
    Dittrich W
    Med Welt; 1967 Oct; 42():2506-8. PubMed ID: 5615284
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apropos of 27 patients treated with bisolvomycin].
    Breuil K
    Bord Med; 1971 Sep; 4(9):2469-70. PubMed ID: 5123583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of a new drug combination in the therapy of acute and chronic bronchopneumopathies].
    Olivieri D; Pezza A; Polistina D; D'Agostino F
    Arch Monaldi; 1979; 34(1-2):29-41. PubMed ID: 554572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bisolvon in the treatment of the tracheo-bronchial secretory syndrome of the laryngectomized].
    Ameli M
    Minerva Med; 1969 Sep; 60(75):3503-8. PubMed ID: 5344810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical considerations on a recent preparation with bronchial secretolytic action].
    Santilli E; Castellana G
    Minerva Med; 1969 Sep; 60(76):3583-93. PubMed ID: 5823755
    [No Abstract]   [Full Text] [Related]  

  • 15. [Respiratory complications after abdominal surgery: therapeutic and diagnostic value of bronchodilator-secretolytic-expectorant preoperative treatment].
    Capria V; Quacquarelli O
    Minerva Med; 1969 Sep; 60(75):3549-56. PubMed ID: 5344815
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with a new secretolytic drug.
    Villa R; Orlandini GC
    Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of a new substance with secretolytic action].
    Bontà L
    Minerva Med; 1969 Sep; 60(75):3525-44. PubMed ID: 5344813
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic action of oxolamine in acute tracheo-bronchitis].
    Gunella G; Fabbri M; Laghi M
    Clin Ter; 1982 Mar; 100(5):485-92. PubMed ID: 7140166
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Brignani F; Cavalli A; Fabbri M; Melica A
    Minerva Med; 1969 Sep; 60(75):3545-8. PubMed ID: 5344814
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bisolvon in pneumological practice].
    Ollagnier C; Vallon MC
    Lyon Med; 1969 Dec; 222(46):1233-5. PubMed ID: 4905093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.